SCHEMBL16317615

SCHEMBL16317615

CC1(C)OC[C@H]([C@H]2OC(c3ccccc3)O[C@@H](COC(=O)c3ccccc3)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ SLC22A1 O15245 1/20 0.40
▸ SYNJ2 O15056 3/20 0.40
▸ MAOB P27338 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ LGALS9 O00182 1/20 0.36
▸ LGALS1 P09382 1/20 0.36
▸ LGALS3 P17931 1/20 0.36
▸ LGALS7; LGALS7B P47929 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ FGF1 P05230 1/20 0.36
▸ FGF2 P09038 1/20 0.36
▸ VEGFA P15692 1/20 0.36
▸ HPSE Q9Y251 1/20 0.36
▸ TSHR P16473 1/20 0.35
▸ SELP P16109 3/20 0.35
▸ TYMP P19971 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12650358 0.89 MEN1 (0.40) ALDH1A1SYNJ2LGALS9LGALS1LGALS3
SCHEMBL12798046 0.89 MEN1 (0.40) ALDH1A1SYNJ2LGALS9LGALS1LGALS3
SCHEMBL12650543 0.89 SLC6A2 (0.37) SYNJ2LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL12798049 0.89 SLC6A2 (0.37) SYNJ2LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL16317613 0.86 TSHR (0.41) ALDH1A1MAPK1LGALS9LGALS1LGALS3
SCHEMBL12798043 0.84 TSHR (0.47) ALDH1A1TSHR
SCHEMBL12798041 0.84 ALDH1A1 (0.49) ALDH1A1SLC22A1SYNJ2POLBGAA
SCHEMBL12650357 0.80 ACHE (0.41) MAOBGAA
SCHEMBL4633222 0.77 MEN1 (0.41) —
SCHEMBL12798042 0.76 TSHR (0.48) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987216-B2 Polysulfated glycosides and salts thereof Teva Hungary Pharmaceutical Marketing Private Limited Company (HU) 2015-03-24 — — US disclosed
US-20110118198-A1 POLYSULFATED GLYCOSIDES AND SALTS THEREOF IVAX DRUG RESEARCH INSTITUTE LTD. (HU) 2011-05-19 — — US disclosed
US-7902158-B2 Polysulfated glycosides and salts thereof Ivax Drug Research Ltd. (HU) 2011-03-08 — — US disclosed
US-20070281893-A1 Polysulfated Glycosides And Salts Thereof IVAX DRUG RESEARCH INSTITUTE LTD (HU) 2007-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118198-A1 POLYSULFATED GLYCOSIDES AND SALTS THEREOF CFTR, AREG, STS ALDH1A1 1189/4885SLC22A1 472/4885SYNJ2 3079/4885
US-20070281893-A1 Polysulfated Glycosides And Salts Thereof CFTR, AREG, STS ALDH1A1 1189/4885SLC22A1 472/4885SYNJ2 3079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback